GlassScriptPhysician profile
Peter T H Wang
NPI 1982656930
$5,496.02
in general payments reported to CMS, 2019-2025
20 companies · $744 in 2025
The $744 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,798 · 2020: $256 · 2021: $378 · 2022: $281 · 2023: $1,282 · 2024: $758 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,553 · Travel and Lodging: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,553.30 |
| Travel and Lodging | $230.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,920.81 | 2019-2025 | |
| Stryker Corporation | $883.54 | 2019-2025 | Vsp System, Vsp Cranial, Delta, Universal Neuro 3 |
| Kls-Martin L.P. | $490.12 | 2020-2023 | |
| Depuy Synthes Sales INC. | $400.38 | 2019-2024 | Na, Trumatch |
| Kerecis Limited | $301.65 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Allergan, INC. | $285.00 | 2019-2022 | |
| Abbvie INC. | $229.89 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Checkpoint Surgical, INC | $211.01 | 2023-2024 | Checkpoint Stimulators |
| Solventum Corporation | $144.27 | 2025 | V.A.C.Ulta, Prevena |
| Mentor Worldwide LLC | $125.00 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Atricure, INC. | $108.00 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Imbed Biosciences INC. | $98.43 | 2023 | |
| Tela Bio, INC. | $72.08 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Osteomed LLC | $64.50 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $45.54 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $35.61 | 2020-2022 | |
| Integra Lifesciences Corporation | $32.69 | 2022 | |
| Medtronic, INC. | $17.49 | 2021 | |
| Bolder Surgical, LLC | $17.19 | 2022 | |
| Teleflex LLC | $12.82 | 2023 | Deknatel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.